Defunct Company
Total Trials
10
As Lead Sponsor
0
As Collaborator
Total Enrollment
3,868
NCT04102995
A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
Phase: Phase 2
Role: Collaborator
Start: Aug 27, 2019
Completion: May 15, 2021
NCT04418531
Convalescent Antibodies Infusion in COVID 19 Patients
Phase: N/A
Start: Jun 1, 2020
Completion: Sep 21, 2022
NCT05178134
A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Start: Nov 8, 2021
Completion: Oct 20, 2022
NCT05458050
An Investigation to Identify Subjects Admitted to Hospital With an Increased Risk of Developing Pressure Ulcers
Start: Sep 1, 2022
Completion: Aug 24, 2023
NCT05699486
A Study to Evaluate the Efficacy, Safety and Tolerability of PDNO Infusion in Patients With Pulmonary Hypertension After Cardiopulmonary Bypass Surgery
Start: Oct 23, 2022
Completion: Dec 31, 2023
NCT06296953
Safety & Feasibility of PERIsign System in Demonstrating Involuntary Muscle Defense as a Sign of Peritonitis in Subjects With Appendicitis
Start: Mar 15, 2024
Completion: Aug 1, 2024
NCT06453707
SpinChip Hs-cTnI Sample Type Validation
Start: Apr 12, 2024
Completion: Jul 3, 2024
NCT06463275
SpinChip Hs-cTnI Determination of the 99th Percentile URL
Start: May 20, 2024
Completion: Aug 30, 2025
NCT06499519
SpinChip Hs-cTnI Clinical Diagnostic Performance
Start: Jul 15, 2024
Completion: Oct 31, 2025
NCT06851013
SpinChip Hs-cTnI Multisite Precision
Start: Feb 3, 2025
Completion: Mar 28, 2025